According to reports from Business Standard, Krsnaa Diagnostics delivered exceptional financial results for Q4 FY26, with consolidated net profit surging 101.74% year-on-year to ₹41.72 crore compared to ₹20.68 crore in Q4 FY25. The company's revenue from operations increased 3.5% YoY to ₹192.60 crore in the quarter ended March 31, 2026. Profit before tax jumped 80.71% to ₹51.70 crore from ₹28.61 crore in the corresponding quarter of the previous fiscal year.
As reported by Business Standard, the company's full-year consolidated net profit increased 30.69% to ₹101.43 crore in FY26, supported by a 7.75% rise in net sales to ₹772.77 crore compared to FY25. This demonstrates the company's consistent growth trajectory across both quarterly and annual performance metrics.
According to Business Standard, Mitesh Dave, Group CEO, highlighted that FY2026 represents a pivotal inflection point for the company's growth journey. The retail diagnostics vertical, Krsnaa Retail, delivered an 8 times jump in revenue and 7 times surge in touchpoints within just twelve months of focused scaling. The retail vertical has expanded to 3,500 locations across 5 states, establishing it as one of the country's most formidable retail diagnostics growth stories. As reported by Business Standard, Dave emphasized that the retail vertical has emerged as a structurally important and independently scalable growth engine for the group.
As reported by Business Standard, the company has recommended a final dividend of ₹2 per equity share of face value ₹5 each (40% of face value) for FY26, subject to shareholders approval at the ensuing AGM. Shares of Krsnaa Diagnostics shed 0.27% to ₹553.65 on the BSE following the results announcement. Krsnaa Diagnostics operates as an integrated diagnostics service provider offering technology-enabled diagnostic services including radiology, pathology, tele-radiology, and clinical laboratory services across India.
